TERESA SPENCER: Open Payments
NPI 1801837026 · JACKSON, MS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,470 in 176 payments from 17 companies in 2025. Trend: 2023 $3,352 · 2024 $2,870 · 2025 $3,470
Food & beverage: $3,470
| Company | Payments | Amount |
|---|---|---|
| GlaxoSmithKline, LLC. | 50 | $913 |
| AstraZeneca Pharmaceuticals LP | 29 | $784 |
| Verona Pharma, Inc. | 20 | $280 |
| Mallinckrodt Hospital Products Inc. | 13 | $259 |
| GENZYME CORPORATION | 12 | $239 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 11 | $197 |
| Electromed, Inc. | 8 | $136 |
| Regeneron Healthcare Solutions, Inc. | 5 | $125 |
| Takeda Pharmaceuticals U.S.A., Inc. | 6 | $107 |
| Insmed, Inc. | 4 | $85 |
Products named: NUCALA, TRELEGY ELLIPTA, AIRSUPRA, DUPIXENT, Ohtuvayre, ACTHAR, TEZSPIRE, BREZTRI.
Industry payments across MS — which companies pay providers there.
